Brief: Oncorus Inc To Build Gmp Viral Immunotherapy Clinical Manufacturing Facility In Andover, Mass
Jan 4 (Reuters) - Oncorus Inc ONCR.O :
* ONCORUS TO BUILD GMP VIRAL IMMUNOTHERAPY CLINICAL
MANUFACTURING
FACILITY IN ANDOVER, MASS.
* ONCORUS INC - INITIAL PHASE OF SITE BUILDOUT ANTICIPATED
TO BE
COMPLETED IN Q4 2021
* ONCORUS INC - COMPANY ANTICIPATES SITE WILL BE FULLY
OPERATIONAL
IN EARLY 2023 AND EXPECTS TO EMPLOY UP TO 100 ONCORUS TEAM
MEMBERS
Source text for Eikon: ID:nGNX9k4dMh
Further company coverage: ONCR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncorus
See all newsBrief: Oncorus Board Unanimously Approves Its Plan Of Dissolution, Liquidation
Brief: Oncorus Board Appoints Brian Shea As Interim CEO
U.S. STOCKS ON THE MOVE-Ford Motor, Theratechnologies, 3D Systems
Oncorus says no cash beyond Q3, cuts remaining jobs, shares tumble
Brief: Oncorus Announces Workforce Reduction Plan